Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Omicron Variant (B.1.1.529): Infectivity, Vaccine Breakthrough, and Antibody Resistance
Jiahui Chen, Rui Wang, Nancy Benovich Gilby, et al.
Journal of Chemical Information and Modeling (2022) Vol. 62, Iss. 2, pp. 412-422
Open Access | Times Cited: 639

Showing 1-25 of 639 citing articles:

An infectious SARS-CoV-2 B.1.1.529 Omicron virus escapes neutralization by therapeutic monoclonal antibodies
Laura A. VanBlargan, John M. Errico, Peter Halfmann, et al.
Nature Medicine (2022) Vol. 28, Iss. 3, pp. 490-495
Open Access | Times Cited: 708
The emergence and epidemic characteristics of the highly mutated SARS‐CoV‐2 Omicron variant
Dandan Tian, Yanhong Sun, Huihong Xu, et al.
Journal of Medical Virology (2022) Vol. 94, Iss. 6, pp. 2376-2383
Open Access | Times Cited: 428
Evolution of the SARS‐CoV‐2 omicron variants BA.1 to BA.5: Implications for immune escape and transmission
Lok Bahadur Shrestha, Charles S. P. Foster, William D. Rawlinson, et al.
Reviews in Medical Virology (2022) Vol. 32, Iss. 5
Open Access | Times Cited: 406
Population Immunity and Covid-19 Severity with Omicron Variant in South Africa
Shabir A. Madhi, Gaurav Kwatra, Jonathan E. Myers, et al.
New England Journal of Medicine (2022) Vol. 386, Iss. 14, pp. 1314-1326
Open Access | Times Cited: 385
Emergence of SARS-CoV-2 Omicron (B.1.1.529) variant, salient features, high global health concerns and strategies to counter it amid ongoing COVID-19 pandemic
Rekha Khandia, Shailja Singhal, Taha Alqahtani, et al.
Environmental Research (2022) Vol. 209, pp. 112816-112816
Open Access | Times Cited: 273
Global emerging Omicron variant of SARS-CoV-2: Impacts, challenges and strategies
Kuldeep Dhama, Firzan Nainu, Andri Frediansyah, et al.
Journal of Infection and Public Health (2022) Vol. 16, Iss. 1, pp. 4-14
Open Access | Times Cited: 199
Alpha to Omicron: Disease Severity and Clinical Outcomes of Major SARS-CoV-2 Variants
Frank Esper, Thamali M. Adhikari, Zheng Jin Tu, et al.
The Journal of Infectious Diseases (2022) Vol. 227, Iss. 3, pp. 344-352
Open Access | Times Cited: 116
Percentage of Asymptomatic Infections among SARS-CoV-2 Omicron Variant-Positive Individuals: A Systematic Review and Meta-Analysis
Weijing Shang, Liangyu Kang, Guiying Cao, et al.
Vaccines (2022) Vol. 10, Iss. 7, pp. 1049-1049
Open Access | Times Cited: 113
SARS‐CoV‐2 Omicron variant: Immune escape and vaccine development
Danyi Ao, Tianxia Lan, Xuemei He, et al.
MedComm (2022) Vol. 3, Iss. 1
Open Access | Times Cited: 105
Omicron variant (B.1.1.529) and its sublineages: What do we know so far amid the emergence of recombinant variants of SARS-CoV-2?
Manish Dhawan, AbdulRahman A. Saied, Saikat Mitra, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 154, pp. 113522-113522
Open Access | Times Cited: 93
Omicron BA.2 (B.1.1.529.2): High Potential for Becoming the Next Dominant Variant
Jiahui Chen, Guo‐Wei Wei
The Journal of Physical Chemistry Letters (2022) Vol. 13, Iss. 17, pp. 3840-3849
Open Access | Times Cited: 83
Omicron (B.1.1.529) variant of SARS‐CoV‐2: Concerns, challenges, and recent updates
Ranjan K. Mohapatra, Ruchi Tiwari, Ashish K. Sarangi, et al.
Journal of Medical Virology (2022) Vol. 94, Iss. 6, pp. 2336-2342
Open Access | Times Cited: 82
Vaccination in patients with kidney failure: lessons from COVID-19
Nina Babel, Christian Hugo, Timm H. Westhoff
Nature Reviews Nephrology (2022) Vol. 18, Iss. 11, pp. 708-723
Open Access | Times Cited: 79
Assessment of mutations on RBD in the Spike protein of SARS-CoV-2 Alpha, Delta and Omicron variants
Clauber Henrique Souza da Costa, Camila Auad Beltrão de Freitas, Cláudio Nahum Alves, et al.
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 78
Clinical Characteristics and Outcomes of Immunocompromised Patients With Coronavirus Disease 2019 Caused by the Omicron Variant: A Prospective, Observational Study
S. Reshwan K. Malahe, Rogier A.S. Hoek, Virgil A. S. H. Dalm, et al.
Clinical Infectious Diseases (2022) Vol. 76, Iss. 3, pp. e172-e178
Open Access | Times Cited: 78
Update on the omicron sub‐variants BA.4 and BA.5
Trina Ekawati Tallei, Saad Alhumaid, Zainab AlMusa, et al.
Reviews in Medical Virology (2022) Vol. 33, Iss. 1
Open Access | Times Cited: 75
Emerging Vaccine-Breakthrough SARS-CoV-2 Variants
Rui Wang, Jiahui Chen, Yuta Hozumi, et al.
ACS Infectious Diseases (2022) Vol. 8, Iss. 3, pp. 546-556
Open Access | Times Cited: 73
Covid-19 and Artificial Intelligence: Genome sequencing, drug development and vaccine discovery
Sali Abubaker Bagabir, Nahla Khamis Ibrahim, Hala Abubaker Bagabir, et al.
Journal of Infection and Public Health (2022) Vol. 15, Iss. 2, pp. 289-296
Open Access | Times Cited: 69
Exploring the Intersection of Artificial Intelligence and Clinical Healthcare: A Multidisciplinary Review
Celina Silvia Stafie, Irina-Georgeta Șufaru, Cristina Mihaela Ghiciuc, et al.
Diagnostics (2023) Vol. 13, Iss. 12, pp. 1995-1995
Open Access | Times Cited: 47
Severity and Outcomes of SARS-CoV-2 Reinfection Compared with Primary Infection: A Systematic Review and Meta-Analysis
Jie Deng, Yirui Ma, Qiao Liu, et al.
International Journal of Environmental Research and Public Health (2023) Vol. 20, Iss. 4, pp. 3335-3335
Open Access | Times Cited: 42
Leveraging artificial intelligence in vaccine development: A narrative review
David B. Olawade, Jennifer Teke, Oluwaseun Fapohunda, et al.
Journal of Microbiological Methods (2024) Vol. 224, pp. 106998-106998
Open Access | Times Cited: 15
Omicron (B.1.1.529 variant of SARS‐CoV‐2); an emerging threat: Current global scenario
Ranjan K. Mohapatra, Ashish K. Sarangi, Venkataramana Kandi, et al.
Journal of Medical Virology (2021) Vol. 94, Iss. 5, pp. 1780-1783
Open Access | Times Cited: 89
Importation and Transmission of SARS-CoV-2 B.1.1.529 (Omicron) Variant of Concern in Korea, November 2021
Ji Joo Lee, Young June Choe, Hyeongseop Jeong, et al.
Journal of Korean Medical Science (2021) Vol. 36, Iss. 50
Open Access | Times Cited: 76
Omicron variant: Current insights and future directions
Rashmi Rana, Ravi Kant, Rohit Singh Huirem, et al.
Microbiological Research (2022) Vol. 265, pp. 127204-127204
Open Access | Times Cited: 66
Page 1 - Next Page

Scroll to top